AbCellera Biologics Inc. (ABCL)
NASDAQ·Healthcare·Biotechnology
$5.24
+0.66%
Mkt Cap $1.60B
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+33.6%
Consensus $7.00 vs current $5.24
NASDAQ·Healthcare·Biotechnology
$5.24
+0.66%
Mkt Cap $1.60B
No recent rating data.
Price Target (8 analysts)
$7.00
Range $7.00 – $7.00
+33.6%
Consensus $7.00 vs current $5.24